toxic shock syndrome

toxic shock syndrome
Field	Infectious disease, critical care medicine

toxic shock syndrome is a rare, life-threatening complication of certain bacterial infections. The condition is often caused by toxins produced by Staphylococcus aureus or Streptococcus pyogenes bacteria. It is characterized by a sudden high fever, a dramatic drop in blood pressure, and a diffuse sunburn-like rash, potentially leading to multi-organ failure. Rapid diagnosis and aggressive treatment in an intensive care unit are critical for survival.

Signs and symptoms

The onset is often abrupt, with symptoms developing rapidly. A hallmark is a high fever, often exceeding 38.9°C (102°F), accompanied by a diffuse, macular erythroderma rash resembling a sunburn, which may later desquamate, particularly on the palms and soles. Profound hypotension, or shock, is a defining feature, potentially leading to end-organ damage. Patients frequently experience myalgia, vomiting, diarrhea, and confusion. Mucous membrane hyperemia, notably in the conjunctiva and vagina, is common. In severe cases, it can progress to disseminated intravascular coagulation, acute respiratory distress syndrome, and failure of the liver or kidneys.

Causes

The syndrome is primarily caused by exotoxins produced by specific strains of bacteria. Staphylococcal cases are frequently associated with superantigen toxins, such as toxic shock syndrome toxin-1 (TSST-1) and certain staphylococcal enterotoxins. Streptococcal cases, sometimes termed streptococcal toxic shock-like syndrome, are often linked to exotoxins like streptococcal pyrogenic exotoxin A. These potent toxins act as superantigens, triggering a massive, dysregulated immune response by non-specifically activating a large population of T cells, leading to a cytokine storm. The original association with high-absorbency tampon use in menstruating women highlighted one portal of entry, but the bacteria can enter through wounds, surgical sites, or other infections like sinusitis.

Risk factors

Historical risk was strongly linked to the continuous use of high-absorbency tampons, particularly those made with polyester foam and carboxymethylcellulose. Other significant risk factors include skin lesions such as burns, surgical wounds, or postpartum infections. The presence of foreign bodies, including surgical sutures or nasal packing, can also increase risk. Individuals with a recent history of influenza or chickenpox may be at higher risk for streptococcal forms. A lack of protective antibodies against specific toxins, such as TSST-1, is a key host factor. Cases have also been reported following procedures like rhinoplasty or arthroscopy.

Diagnosis

Diagnosis is primarily clinical, based on criteria established by the Centers for Disease Control and Prevention. Key criteria include fever, hypotension, rash with subsequent desquamation, and involvement of three or more organ systems (e.g., gastrointestinal, muscular, renal, hepatic, hematologic, central nervous system). Laboratory findings often show elevated creatine kinase, thrombocytopenia, and evidence of acute kidney injury. Cultures from a sterile site (e.g., blood, cerebrospinal fluid) or a non-sterile site (e.g., vagina, wound) may grow Staphylococcus aureus or Streptococcus pyogenes. Differentiation from other conditions like Kawasaki disease, scarlet fever, or Rocky Mountain spotted fever is essential.

Prevention

Preventive measures for menstrually-associated cases include using low-absorbency tampons and alternating with menstrual pads, changing tampons frequently, and avoiding overnight tampon use. Proper wound care for burns, surgical incisions, and other skin breaks is crucial. Prompt and appropriate treatment of localized infections like cellulitis or abscesses can prevent progression. In hospital settings, strict adherence to asepsis during procedures and proper management of surgical drains reduces risk. Education on symptoms for high-risk individuals allows for earlier medical intervention.

Treatment

Immediate, aggressive treatment in a hospital setting is required. The cornerstone is aggressive fluid resuscitation and vasopressor support to manage shock and hypotension. Source control is critical, involving removal of any foreign body (e.g., tampon, packing) and surgical debridement of infected wounds. Empiric, broad-spectrum intravenous antibiotics that cover both Staphylococcus aureus (including MRSA) and Streptococcus pyogenes are administered immediately; common regimens include vancomycin or daptomycin combined with clindamycin, which inhibits toxin production. Intravenous immunoglobulin may be given to neutralize circulating toxins and modulate the immune response.

Prognosis

The prognosis depends heavily on the speed of diagnosis and initiation of treatment. With prompt and aggressive intensive care, survival rates have improved significantly, though mortality remains substantial, especially for streptococcal cases. Early complications can include prolonged shock requiring support with medications like norepinephrine, and organ failure necessitating interventions such as renal replacement therapy. Long-term sequelae may include cognitive impairment, muscle weakness, and emotional distress from the acute illness. Recurrence is possible, particularly in individuals who do not develop protective antibodies, necessitating ongoing patient education and caution regarding risk factors.

Category:Medical emergencies Category:Bacterial diseases Category:Infectious diseases